Dimensions of quality of life and self-monitoring therapy with oral anticoagulants - Still research or everyday practice?

Seminars in Thrombosis and Hemostasis

Volumn 25, Issue 1, 1999, Pages 117-122

  Wenzel, Thomas ^a   Mörsdorf, Stefan ^a,b   Sibitz, Ingrid ^a   Schenck, Joachim F ^a,b   Griengl, Hemma ^a   Erdlenbruch, Wolfhardt ^a,b   Heinrich, Walter ^a   Krischek, Boris ^c   Birner, Peter ^c   Harenberg, Job ^c  

^a University Hospital for Psychiatry   (Austria)

^b SAARLAND UNIVERSITY   (Germany)

^c University Hospital for Psychiatry ^*

Author keywords

Oral anticoagulation; Quality of life; Self management

Indexed keywords

ANTICOAGULANT AGENT;

ADOLESCENT; ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; DEPRESSION; FEMALE; HOME MONITORING; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; OUTPATIENT CARE; PATIENT SATISFACTION; PRIORITY JOURNAL; QUALITY OF LIFE; SLEEP DISORDER; TREATMENT OUTCOME;

EID: 0032930649     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-996434     Document Type: Article

References (21)

1. 1. Katschnig H. How useful is the concept of quality of life in Psychiatry? In: Katschnig H, Freeman H, Sartorius N, eds. Quality of Life in Mental Disorders. Chichester: John Wiley; 1997: 3-15
2. 2. Salvador-Carulla L. Measuring quality of life in cost-analysis: Controversies and use in mental health. In: Katschnig H, Freeman H, Sartorius N, eds: Quality of Life in Mental Disorders. Chichester: John Wiley; 1997:287-304
3. 3. Sartorius N. A WHO method for the assessment of health-related quality of life (WHOQOL), in quality of life assessment: Key issues in the 1990s. In Walker SR, Rosser RM, eds. London: Kluwer Academic; 1993:201-207
4. 4. Calman KC. Qualily of life in cancer patients - A hypothesis. J Med Ethics 1984;10:124-127
5. 5. Karnofsky DA, Burchenal JH. The clinical evaluation of chemotherapeutic agents in cancer. In: MacLeod CM, ed. Evaluation of Chemotherapeutic Agents. New York: Columbia University Press; 1949:191-205
6. 6. Wulff HR. Quality of life and treatment for proximal deep-vein thrombosis. Lancet 1994;344:420-421
7. 7. Rawles J, Light J. Loss of quality adjusted days as a trial endpoint: Effect of early thrombolytic treatment in suspected myocardial infarction. Grampion Region Early Anistreplase Trial (GREAT). J Epidemiol Community Health 1993;47:377-381
8. 8. Kulinna W, Ney D, Wenzel T, Heene DL, Harenberg J. The effect of self-monitoring of INR on quality of anticoagulation and quality of life Semin Thromb Hemostas 1999;25:123-126
9. 9. Wallston KA, Wallston BS. Health locus of control scales. In: Lefcourt H., ed. Research with the Locus of Control Construct, Vol. 1. New York: Academic Press; 1981:189-241
10. 10. Lernmark B, Dahlqvist G, Fransson P, et al. Relations between age, metabolic control, disease adjustment and psychological aspects in insulin-dependent diabetes mellitus. Acta Paediatr 1996;85:818-824
11. 11. Peyrot M, Rubin RR. Structure and correlates of diabetes-specific locus of control. Diabetes Care 1994;17:994-1001
12. 12. Lin CC, Liang CC. The relationship between health locus of control and compliance of hemodialysis patients. Kao Hsiung 1 Hsueh Ko Hsueh Tsa Chih 1997;13:243-254
13. 13. Mörsdorf S, Leipnitz G, Pindur G, et al. Improved therapeutic safety of oral auticogulants: The Saarland Model. Semin Thromb Hemostas 1999;25:49-56
14. 14. Gilden JL, Casia C, Hendryx M, Singh SP. Effects of self-monitoring of blood glucose on quality of life in elderly diabetic patients. J Am Geriatr Soc 1990;38:511-515
15. 15. Muchmore DB, Springer J, Miller M. Self-monitoring of blood glucose in overweight type 2 diabetic patients. Acta Diabetol 1994;31:215-219
16. 16. Ross DD, Soumerai SB, Avorn J, et al. Hemophilia home treatment. Economic analysis and implications for health policy. Int J Technol Assess Health Care 1995;11:327-344
17. 17. Koopman MM, Prandoni P, Piovella F, et al. Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study Group. N Engl J Med 1996;334:682-687
18. 18. Anderson DR, Harrison L, Hirsh J. Evaluation of a portable Prothrombin Time Monitor for home use by patients who require long-term oral anticoagulant therapy. Arch Intern Med 1993;153:1441-1447
19. 19. Jacobson AM, de Groot M, Samson JA. The effect of psychiatric-disorders and symptoms on quality of life in patients with Type I and Type II diabetes. Qual Life Res 1997;6:191-192
20. 20. Beyth RJ, Cohen AM, Landefeld CS. Long-term outcomes of deep-vein thrombosis. Arch Intern Med 1995;155:1031-1037
21. 21. Kohlmann CW, Kuestner E, Schuler M, Tausch A. Der IPC-Diabetes-Fragebogen (IPC-D1). Ein Inventar zur Erfassung krankheitsspezifischer Kontrollueberzeugungen bei Typ-1-Diabetes mellitus. Bern: Huber; 1994